DELCF) seems ideally positioned to benefit from continued growth in the psychedelic wellness industry


News and research before you hear about it on CNBC et al. Claim your 1-week free trial for StreetInsider Premium here.

  • Delic has positioned itself as a leading psychedelic wellness platform, with companies spanning all corners of the industry.
  • Latest announced acquisition of Delic will make it the largest operating chain of psychedelic wellness clinics in the United States
  • The psychedelic wellness industry has seen robust growth in recent times, following the FDA’s decision to grant psilocybin “breakthrough therapy” status in 2018.
  • Denver and Oakland were among the first U.S. cities to decriminalize the use of psilocybin mushrooms, with California currently exploring whether to follow suit.
  • Psychedelic Drug Market Expected To Reach $ 10.75 Billion By 2027

When Michael Pollard started writing his seminal book, How to change your mind in 2018, the psychedelic wellness industry was a whole different world than what we know today ( Although the psychedelic industry has a long history in America dating back to the 1950s, it is only in recent years that scientific research into the world of psychedelics and their associated compounds has discovered their potential to provide relief to a wide range. range of mental suffering, including depression. , anxiety and addiction. Delic Holdings (CSE: DELC) (OTCQB: DELCF) has sought to capitalize on the transformation underway within the industry, positioning itself as the leading psychedelic wellness platform committed to bringing science benefits to all and reframing the conversation. psychedelic.

Originally formed in 2019 to respond to growing interest within the science-backed psychedelic wellness industry, Delic has grown into a sprawling conglomerate with services spanning all areas of the industry. The company’s related activities now include trusted media and e-commerce platforms like &


NOTICE TO INVESTORS: The latest DELCF news and updates are available in the company newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialty content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advancements of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly inform investors on important industry news, (3) relies on a team of expert editors to improve press releases for maximum impact, (4) help companies manage and optimize social media on a range of platforms, and (5) provides unparalleled business communication solutions. PNW keeps abreast of the latest information and has built a reputation as a go-to source for coverage of psychedelics, therapies and emerging market opportunities. Our team of seasoned journalists have a proven track record of helping public and private companies gain traction with a broad audience of investors, consumers, media and the general public by leveraging our extensive broadcast network of over 5,000 key syndication points. PNW is committed to providing enhanced brand visibility and recognition to companies operating in emerging psychedelic markets.

To receive instant SMS alerts, send “Groovy” to 21000 (US mobile phones only)

For more information, please visit

Please review the full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever posted or republished: Disclaimer

Do you have any questions or are you interested in working with PNW? Ask our editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Leave A Reply

Your email address will not be published.